Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer
Published date:
08/19/2020
Excerpt:
...we treated a panel of PCa cell lines with specific DOT1L inhibitor EPZ004777, AR-positive CRPC cells (C42B), AR variant AR-V7 expressing cells (22Rv1) and ENZA resistant cells were all sensitive to DOT1L inhibitor.